Reuters: Health
Sol-Gel Technologies Ltd's shares more than tripled in value on Monday after the company said its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.
Sol-Gel acne cream reduces marks in late-stage studies, shares soar
Sol-Gel acne cream reduces marks in late-stage studies, shares soar
Reuters: Health
Sol-Gel Technologies Ltd's shares more than tripled in value on Monday after the company said its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.
Reuters: Health
Sol-Gel Technologies Ltd's shares more than tripled in value on Monday after the company said its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment